Screener
Globus Medical GMED EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Globus Medical in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Globus Medical’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054450
| (In thousands, except per share amounts) | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Total other comprehensive income/(loss), net of tax | (3,208) | 12,406 | (4,150) | 17,100 |
| Comprehensive income/(loss) | $148,361 | $215,252 | $271,721 | $295,408 |
| Earnings per share: | ||||
| Basic | $1.12 | $1.50 | $2.04 | $2.05 |
| Diluted | $1.10 | $1.49 | $2.00 | $2.01 |
| Weighted average shares outstanding: | ||||
| Basic | 135,054 | 135,205 | 135,209 | 135,981 |
| Diluted | 137,384 | 136,499 | 137,787 | 138,137 |
Item 1. Financial Statements
FAQ
- What is Globus Medical's EPS (diluted)?
- Globus Medical (GMED) reported EPS (diluted) of $1.10 in Q2 2026.
- How has Globus Medical's EPS (diluted) changed year-over-year?
- Globus Medical's EPS (diluted) decreased by 26.2% year-over-year, from $1.49 to $1.10.
- What is the long-term trend for Globus Medical's EPS (diluted)?
- Over 4 years (2021 to 2025), Globus Medical's EPS (diluted) has grown at a 28.8% compound annual growth rate (CAGR), from $1.43 to $3.93.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Globus Medical's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude